Insys Founder Tries to Shift Blame in Opioid Trial to Staff

  • Kapoor accused of racketeering, conspiracy over Subsys sales
  • Insys became a criminal pact, U.S. says at start of trial
John Kapoor leaves U.S. District Court in Phoenix on Oct. 26, 2017.Photographer: Ross D. Franklin/AP Photo
This article is for subscribers only.

Insys Therapeutics Inc. founder John Kapoor didn’t know underlings were cutting side deals with doctors who got fees for writing prescriptions of his company’s opioid-based painkiller, his lawyer told a Boston jury at the start of his racketeering trial.

Alec Burlakoff, a former Insys sales executive, sought to block Kapoor from reviewing payments to doctors who wrote prescriptions for the Subsys painkiller so the manager could have “free rein’’ over the project, Beth Wilkinson, Kapoor’s lawyer, said Monday in her opening statement.